22nd Closed Scientific Expert Meeting of the Editorial Board

Developing single-course gene editing medicines to inactivate PCSK9 and treat cardiovascular disease
Reports from the 22nd Virtual Closed Scientific Expert Meeting of the Editorial Board Amit Khera
read more »
siRNA therapeutics: What does a clinician need to know?
Reports from the 22nd Virtual Closed Scientific Expert Meeting of the Editorial Board Marie Wikström Lindholm
read more »
The status of access to PCSK9 inhibitors in ASCVD patients around the world – Setting the scene
Reports from the 22nd Virtual Closed Scientific Expert Meeting of the Editorial Board Henry Ginsberg
read more »
Cost-effectiveness of PCSK9 inhibitors: Past, present and future
Reports from the 22nd Virtual Closed Scientific Expert Meeting of the Editorial Board Anthony Wierzbicki
read more »
PCSK9 inhibition and post-prandial atherogenesis
Reports from the 22nd Virtual Closed Scientific Expert Meeting of the Editorial Board Cédric Le May
read more »
ANGPTL3: A cholesterol target?
Reports from the 22nd Virtual Closed Scientific Expert Meeting of the Editorial Board Rob Hegele
read more »